Skip to main content
. Author manuscript; available in PMC: 2015 Jun 23.
Published in final edited form as: J Policy Pract Intellect Disabil. 2010 Sep 2;7(3):204–210. doi: 10.1111/j.1741-1130.2010.00266.x

Table 3.

Prevalence of Disability-Associated Conditions and Chronic Diseases for IDD and Control Cohorts.

IDD Cohort Control Cohort
Condition (ICD-9 Code) N % N % Odds Ratio (95% CI) P-value*
Disability-Associated Conditions Blindness and Low Vision (369) 44 3.5 29 1.1 3.1 (1.9,5.0) <0.001
Hearing Loss (389/744.0) 123 9.7 86 3.4 3.1 (2.3,4.1) <0.001
Epilepsy (345/780.39) 290 22.9 132 5.2 5.4 (4.3,6.7) <0.001
GERD (530.8/530.1) 291 23.0 518 20.4 1.2 (0.99,1.4) 0.073
Constipation (564) 239 18.9 250 9.9 2.1 (1.8,2.6) <0.001
Osteoporosis (733) 161 12.7 247 9.8 1.3 (1.09,1.7) 0.006
Spasticity (343) 378 29.8 0 0.0 -- <0.001
Chronic Diseases Hypertension (401) 313 24.7 841 33.2 0.66 (0.57,0.77) <0.001
Diabetes (250/357.2/362.0/366.41) 131 10.3 384 15.2 0.65 (0.52,0.80) <0.001
Obesity (278.0–278.8) 232 18.3 390 15.4 1.2 (1.03,1.5) 0.022
Osteoarthritis (715) 148 11.7 355 14.0 0.81 (0.66,1.00) 0.046
Hyperlipidemia (272.0–272.4) 443 35.0 800 31.6 1.2 (1.01,1.3) 0.036
Congestive Heart Failure (428) 20 1.6 100 4.0 0.39 (0.24,0.63) <0.001
Coronary Heart Disease (414/429.2) 44 3.5 196 7.7 0.43 (0.31,0.60) <0.001
Chronic Obstructive Pulmonary Disease (491/492/494/496) 41 3.2 145 5.7 0.55 (0.39,0.78) <0.001
Asthma (493) 151 11.9 34 13.5 0.86 (0.70,1.06) 0.16
*

Pearson’s Chi-square